Add the specialty areas of your choice to tailor excemed.org to your professional interests.
Save & Create free account
No thanks, just apply selection
I already have an account. Login

User login

We offer our registered users tailored information, free online courses and exclusive content.

Can't find your password?
Reset it here.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

MS Academia: Multiple sclerosis advanced course

PART OF MS Alumni FEATURE
MS Academia: Multiple sclerosis advanced course
  • Neurology
  • Multiple sclerosis
Workshop by Excemed
Tuesday, Sep 13 2016
London, United Kingdom

Language

English

Registration status
Closed

To register for this event, contact

Meridiano Congress International
Congress Manager: Sara Guglielmini
T +39 06 88 595 211 - F +39 06 88 595 234
sara.guglielmini@meridiano.it

Registration fee

200.00€

The registration fee is  € 200,00 and includes:

  • Scientific sessions
  • Coffee breaks and luncheon
  • Educational materials
  • Certificate of attendance

Target audiences

This programme is appropriate for neurologists who specialize in MS as well as other clinicians with a special interest or focus on this disease.

Files

Introduction

Access the post-event resources by scrolling down to the Scientific Programme or by clicking on the Outcomes tab.

 

This live educational course is endorsed by ECTRIMS (European Committee for Treatment and Research In Multiple Sclerosis).

Overview

Multiple sclerosis (MS) is a multifaceted neurological disorder whose management requires a multidisciplinary team of highly specialised health professionals. The availability of new and sophisticated diagnostic tools and the discovery of new treatments has made daily clinical practice even more challenging for physicians involved in MS patient management. Tailoring the treatment to individual patient needs and establishing the right time to start therapy or to switch from traditional first-line disease-modifying therapies to other first- or second-line therapies are the biggest issues. The goal of this learning activity is to update participants about MS pathogenesis and diagnostic criteria and to provide a comprehensive overview of past and future disease-modifying therapies. In addition, the learner will be taught about strategies for symptomatic and rehabilitative care which have proven to be a necessity in overall MS management. A clinical cases based approach will be used to stimulate discussion and scientific exchange between participants and the panel of MS experts.

Learning objectives

  • Illustrate the immunological factors involved in the pathogenesis of multiple sclerosis
  • Integrate clinical, neurophysiological, and MRI findings into the accurate diagnosis of multiple sclerosis and the exclusion of MS mimickers
  • Incorporate information regarding the risks and benefits of currently available drugs for multiple sclerosis into treatment decisions
  • Include symptomatic management of multiple sclerosis into the treatment paradigm of comprehensive management throughout the spectrum of the disease

Accreditation details

The  EXCEMED  “MS  Academia:  Multiple  sclerosis  advanced  course”  is  accredited  by  the  European  Accreditation  Council  for
Continuing  Medical  Education  (EACCME ® )  to  provide  the  following  CME  activity  for  medical  specialists.  The  EACCME ® is  an
institution of the European Union of Medical Specialists (UEMS), www.uems.net


The CME “MS Academia: Multiple sclerosis advanced course” held on 13 September 2016 in London, UK, is designated for a
maximum of 6 (six) hours of European external CME credits (ECMEC). Each medical specialist should claim only those credits that
he/she actually spent in the educational activity.


Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may
convert  EACCME ® credits  to  an  equivalent  number  of  AMA  PRA  Category  1  Credits™.  Information  on  the  process  to  convert
EACCME ® credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.


Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be
Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of
Physicians and Surgeons of Canada.

MS Alumni

The MS Alumni programme is an educational initiative of EXCEMED that is intended to provide ongoing support for young physicians and specialists in neurology.

Scientific programme

Tuesday, 13 September 2016


08.15 Opening and introduction
G. Comi (Italy)  - H.P. Hartung (Germany) - F.D. Lublin (USA)

Session I: Etiology and pathogenisis

Chairs: H.P. Hartung (Germany) - F.D. Lublin (USA)


08.30 L1: Genes, J. Hillert (Sweden)
Slide presentation Video
 


09.00  L2: Environmental factors and microbiota, A. Ascherio (USA)


09.30  L3: Pathology, W. Brück (Germany)
Slide presentation Video
 


10.00  L4: Immunopathogenesis: the crosstalk between B and T cells, A. Bar-Or (Canada)
Slide presentation Video


10.30    Session discussion


10.40  Coffee break

Session II: Diagnosis. Case based story session

Chairs: G. Comi (Italy) - F. D. Lublin (USA)


This session will propose a practice-based approach to the key elements of MS diagnosis. Presenters will offer actual examples from their own clinical experiences to effectively illuminate the most important diagnostic elements of MS.


11.00 CBS1: Diagnosis and differential diagnosis, M. Tintoré (Spain)
Slide presentation Video


11.30 CBS2: MRI in diagnosis and monitoring of MS and treatments, M.A. Rocca (Italy)
Slide presentation Video


12.00 CBS3: Neurophysiology in diagnosis and monitoring of MS, L. Leocani (Italy)
Slide presentation Video
 

12.30  L5: Assessment of treatment response, R. Fox (USA)
Slide presentation Video
 

13.00  Session discussion
 

13.10   Lunch

Session III: Treatment

Chairs: H.P. Hartung (Germany) - G. Comi (Italy)
 

14.20     L6: Efficacy and safety of immunomodulators in RR MS, M.S. Freedman (Canada)
Slide presentation Video
 

14.50     L7: Efficacy and safety of immunosuppressants in RR MS, G. Giovannoni (UK)
Slide presentation Video
 

15.20     Coffee break
 

15.40 L8: Treatment individualization and new treatment algorithms, G. Comi (Italy)
Slide presentation Video
 

16.10    L9: Pharmacological and non pharmacological approach to progressive MS, A. J. Thompson (UK)
 

16.40    L10: Future therapies,  H. P. Hartung (Germany)
 

17.10  Session discussion
 

17.20     PD: Treatment in Practice – Panel discussion
 G. Comi (Italy); M. Freedman (Canada); G. Giovannoni (UK); F. Lublin (USA)
 

17.50  Concluding remarks

            
End of the course

CME provider

EXCEMED - Excellence in Medical Education
Programme Manager: Giulia Anastasia
T +39 06 420413 315 - F +39 06 420413 677
giulia.anastasia@excemed.org
Medical Advisor: Doriana Landi
doriana.landi@gmail.com

Chair(s)

Hans Peter Hartung

Director of the Center for Neuropsychiatry and Chair of the Department of Neurology
Department of Neurology
Heinrich-Heine-University Duesseldorf
Dusseldorf, Germany

Fred D. Lublin

Corinne Goldsmith Dickinson Center for Multiple Sclerosis
Icahn School of Medicine at Mount Sinai
New York, United States
Speakers

Alberto Ascherio

Professor of Epidemiology and Nutrition; Professor of Medicine
Department of Epidemology and Nutrition
Harvard T.H. Chan School of Public Health
655 Huntington Avenue
Building II 3rd Floor
Boston, Massachusetts, 02115, United States

Amit Bar-Or

Neurologist and Professor
Department of Neurology and Neurosurgery
Clinical Research Unit
Montreal Neurological Institute
Montreal, Canada

Wolfgang Brück

Dean of Research and Infrastructure
Faculty of Medicine
Georg-August University
Göttingen, Germany
Professor of Neuropathology and Director of the Department of Neuropathology
Institute of Neuropathology
University Medical Centre Göttingen

Mark Freedman

Professor of Medicine
Neurology
University of Ottawa
Ottawa, Canada
Senior Scientist and Director of the Multiple Sclerosis Research Unit
Multiple Sclerosis Research Unit
Ottawa Hospital Research Institute
Ottawa, Ontario, Canada

Robert James Fox

Mellen Center for MS
Cleveland Clinic
Cleveland, Ohio, United States

Gavin Giovannoni

Chair of Neurology
Department of Neurology
Institute of Cell and Molecular Science
Queen Mary University London & Barts and The London NHS Trust
London, United Kingdom

Hans Peter Hartung

Director of the Center for Neuropsychiatry and Chair of the Department of Neurology
Department of Neurology
Heinrich-Heine-University Duesseldorf
Dusseldorf, Germany

Jan Hillert

Department of Clinical Neuroscience
Karolinska Institute
Stockholm, Sweden

Letizia Leocani

Institute of Experimental Neurology
University Vita-Salute IRCCS
Milan, Italy

Fred D. Lublin

Corinne Goldsmith Dickinson Center for Multiple Sclerosis
Icahn School of Medicine at Mount Sinai
New York, United States

Maria Assunta Rocca

Head of the “Neuroimaging of CNS White Matter Unit”
Department of Neurology
Institute of Experimental Neurology
Milan, Italy

Alan Thompson

Department of Brain Repair and Rehabilitation
Institute of Neurology
National Hospital for Neurology and Neurosurgery
Queen Square
London, United Kingdom

Mar Tintorè

Neurology-Neuroimmunology Department
Multiple Sclerosis Centre of Catalonia (Cemcat)
Vall d’Hebron University Hospital
Barcelona, Spain
Video
Wolfgang Brück
Neurology
Slide kit
Wolfgang Brück
Neurology
Slide kit
Anthony Feinstein
Neurology
Slide kit
Robert James Fox
Neurology
Video
Robert James Fox
Neurology
Slide kit
Mark Freedman
Neurology
Slide kit
Gavin Giovannoni
Neurology
Video
Jan Hillert
Neurology
Slide kit
Jan Hillert
Neurology
Slide kit
Letizia Leocani
Neurology
Slide kit
Maria Assunta Rocca
Neurology
Video
Mar Tintorè
Neurology
Slide kit
Mar Tintorè
Neurology